Major changes in prevalence and genotypes of rotavirus diarrhea in Beijing, China after RV5 rotavirus vaccine introduction
Journal of Medical Virology · 2024
DOI: 10.1002/jmv.29650 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, 2024. Verfasst von Yi Tian und 12 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Infectious Disease and Endemic Disease Control, Beijing Municipal Center for Disease Prevention and Control, Beijing, China. Hauptthemen laut MEDLINE: Rotavirus, Rotavirus Infections, Diarrhea, Genotype. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: High-level Public Health Technical Talents Construction Project.
Abstract (Originalsprache)
To analyze the epidemiological characteristics of group A rotavirus (RVA) diarrhea in Beijing between 2019 and 2022 and evaluate the effectiveness of the RV5 vaccine. Stool specimens were collected from patients with acute diarrhea, and RVA was detected and genotyped. The whole genome of RVA was sequenced by fragment amplification and Sanger sequencing. Phylogenetic trees were constructed using Bayesian and maximum likelihood methods. Descriptive epidemiological methods were used to analyze the characteristics of RVA diarrhea. Test‐negative design was used to evaluate the vaccine effectiveness (VE) of the RV5. Compared with 2011–2018, RVA‐positive rates in patients with acute diarrhea under 5 years of age and adults decreased significantly between 2019 and 2022, to 9.45% (249/634) and 3.66% (220/6016), respectively. The predominant genotype of RVA had changed from G9‐VIP[8]‐III between 2019 and 2021 to G8‐VP[8]‐III in 2022, and P[8] sequences from G8‐VP[8]‐III strains formed a new branch called P[8]‐IIIb. The complete genotype of G8‐VP[8]‐III was G8‐P[8]‐I2‐R2‐C2‐M2‐A2‐N2‐T2‐E2‐H2. The VE of 3 doses of RV5 was 90.4% (95% CI : 28.8%–98.7%) against RVA diarrhea. The prevalence of RVA decreased in Beijing between 2019 and 2022, and the predominant genotype changed to G8P[8], which may be related to RV5 vaccination. Continuous surveillance is necessary to evaluate vaccine effectiveness and improve vaccine design.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Infectious Disease and Endemic Disease Control, Beijing Municipal Center for Disease Prevention and Control, Beijing, China.
ORCID-Profile: Yi Tian, Zhiyong Gao, Quanyi Wang
Förderung
- High-level Public Health Technical Talents Construction Project
Zitieren
APA
Tian, Y., Shen, L., Li, W., Yan, H., Fu, J., Liu, B., Wang, Y., Jia, L., Li, G., Suo, L., Zhang, D., Gao, Z., & Wang, Q. (2024). Major changes in prevalence and genotypes of rotavirus diarrhea in Beijing, China after RV5 rotavirus vaccine introduction. Journal of Medical Virology. https://doi.org/10.1002/jmv.29650
Vancouver
Tian Y, Shen L, Li W, Yan H, Fu J, Liu B, et al. Major changes in prevalence and genotypes of rotavirus diarrhea in Beijing, China after RV5 rotavirus vaccine introduction. Journal of Medical Virology. 2024. doi:10.1002/jmv.29650
BibTeX
@article{Tian2024,
author = {Tian, Yi and Shen, Lingyu and Li, Weihong and Yan, Hanqiu and Fu, Jiamei and Liu, Baiwei and Wang, Yu and Jia, Lei and Li, Gang and Suo, Luodan and Zhang, Daitao and Gao, Zhiyong and Wang, Quanyi},
title = {Major changes in prevalence and genotypes of rotavirus diarrhea in Beijing, China after RV5 rotavirus vaccine introduction},
journal = {Journal of Medical Virology},
year = {2024},
doi = {10.1002/jmv.29650}
}
EUVIMED